Publications by authors named "Judith Rusch"
Article Synopsis
- Adjuvant treatments like immune checkpoint inhibitors (ICI) and targeted therapy (TT) significantly improve disease-free survival for high-risk melanoma patients, but treatment decisions are heavily influenced by potential side effects and toxicity risk.
- A study involving 108 dermatooncologists from Germany and Switzerland surveyed their attitudes towards these treatments, revealing that physicians have a different perspective on the severity of side effects compared to patients.
- Physicians were found to be less concerned about treatment-related side effects and required lower expectations for improvements in survival rates to accept the risks, highlighting a notable difference in treatment decision-making between doctors and patients.
Background: Topical agents are an essential component of psoriasis therapy.
Objectives: To develop a new version of the patient-reported Patient Benefit Index assessing the importance and achievement of treatment goals in topical psoriasis therapy in adult patients (PBI-TOP).
Methods: Through semi-structured interviews, focus groups and free-text questionnaires, patients reported their needs in topical treatment.